ImmunoPrecise Antibodies (IPA)
(Delayed Data from NSDQ)
$0.73 USD
-0.04 (-4.58%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $0.70 -0.03 (-4.10%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/12/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.52 |
Last EPS Surprise | -420.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.25 |
Next Year | -0.14 |
EPS (TTM) | -0.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.96M | 5.40M | 21.75M | 26.54M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 4.96M | 5.40M | 21.75M | 26.54M |
Low Estimate | 4.96M | 5.40M | 21.75M | 26.54M |
Year ago Sales | 4.26M | 4.50M | 18.13M | 21.75M |
Year over Year Growth Est. | 16.43% | 20.00% | 19.99% | 22.02% |
Earnings Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.04 | -0.25 | -0.14 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.09 | NA | -0.25 | -0.14 |
High Estimate | -0.09 | -0.04 | -0.25 | -0.14 |
Low Estimate | -0.09 | -0.04 | -0.25 | -0.14 |
Year ago EPS | -0.11 | -0.07 | -0.78 | -0.25 |
Year over Year Growth Est. | 18.18% | 42.86% | 67.95% | 44.00% |
Agreement - Estimate Revisions
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Current | -0.09 | -0.04 | -0.25 | -0.14 |
7 Days Ago | -0.09 | -0.04 | -0.25 | -0.14 |
30 Days Ago | -0.07 | -0.04 | -0.26 | -0.12 |
60 Days Ago | -0.07 | -0.04 | -0.26 | -0.12 |
90 Days Ago | -0.07 | -0.04 | -0.26 | -0.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.04 | -0.25 | -0.14 |
Zacks Consensus Estimate | -0.09 | -0.04 | -0.25 | -0.14 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (4/2024) |
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.52 | -0.08 | -0.07 | -0.11 | NA |
Estimate | -0.10 | -0.08 | -0.09 | -0.17 | NA |
Difference | -0.42 | 0.00 | 0.02 | 0.06 | -0.09 |
Surprise | -420.00% | 0.00% | 22.22% | 35.29% | -90.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more